Jiaxi Zhou

Jiaxi Zhou

BeiGene - Beijing / China
Medical and Health Sciences / Hematology
AD Scientific Index ID: 5097135
person_outline Jiaxi Zhou's MOST POPULAR ARTICLES
1-) FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphomaM Merino, Y Kasamon, H Li, L Ma, R Leong, J Zhou, G Reaman, ...Pediatric Blood & Cancer 69 (8), e29602, 2022212022
2-) Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvementLL Fernandes, J Zhou, B Kanapuru, E Horodniceanu, T Gwise, PG Kluetz, ...Blood Cancer Journal 11 (8), 148, 2021192021
3-) Response rate, event-free survival, and overall survival in newly diagnosed acute myeloid leukemia: US Food and Drug Administration trial-level and patient-level analysesKJ Norsworthy, X Gao, CW Ko, ED Pulte, J Zhou, Y Gong, YL Shen, ...Journal of Clinical Oncology 40 (8), 847-854, 2022192022
4-) Overview of oncology and hematology drug approvals at US Food and Drug Administration between 2008 and 2016J Zhou, J Vallejo, P Kluetz, R Pazdur, T Kim, P Keegan, A Farrell, ...JNCI: Journal of the National Cancer Institute 111 (5), 449-458, 2019192019
5-) Nonproportional hazards—an evaluation of the maxcombo test in cancer clinical trialsYL Shen, X Wang, M Sirisha, F Mulkey, J Zhou, X Gao, L Zhang, T Gwise, ...Statistics in Biopharmaceutical Research 15 (2), 300-309, 2023122023